US FDA investigates death tied to Takeda's blood disorder drug

Takeda Pharmaceutical

21/11/2025 16:42

Nov 21 (Reuters) - The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' 4502.T blood disorder drug, the health regulator said on Friday.

 (Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)

 ((Kamal.Choudhury@thomsonreuters.com;))